GLP1R and Parkinson disease: Our results also illustrated that these inflammation responses could be alleviated in the EcN‐GLP‐1 and exenatide groups, and noticeably, using EcN alone just showed no or slightly actions in regulating these inflammatory pathways in PD (Figure 4).